跳至主要内容
临床试验/NCT03687060
NCT03687060Unknown不适用

Behavioral Economics and Implementation Research to Reduce Cardiovascular Risk in HIV-Infected Adults

University of California, Los Angeles8 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2019年3月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
75
试验地点
8
主要终点
Change in proportion of PLWH with cardiovascular risk factors seen by a physician receiving statin therapy

研究概览

简要总结

Cardiovascular disease is a major cause of morbidity and mortality among people living with HIV. Recent studies have demonstrated that patients with HIV experience a 50-100% increased risk of myocardial infarction and stroke compared to HIV-uninfected persons. They also face higher risks of stroke, sudden death, and heart failure. However, evidence-based statin therapy-which is safe in this population and highly effective at reducing cardiovascular risk-is under-prescribed. The investigators propose a multi-level intervention to increase evidence-based statin prescribing by addressing barriers at these levels. The implementation intervention includes two strategies: (1) tailored education at the leadership, provider, and patient levels, and (2) behavioral economics-informed feedback for providers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •age ≥ 40 years
  • •have been diagnosed with HIV
  • •LDL ≥ 190, diabetes and LDL ≥ 70
  • •or 10-year ASCVD risk ≥ 7.5%
  • •or history of heart attack, stroke, or peripheral vascular disease
  • •care for patients with HIV at least 1/2 day each week (physicians)
  • •work at participating clinics (physicians)

排除标准

  • •unable to provide written, informed consent
  • •not at participating clinic

研究组 & 干预措施

Patient Level

Other

干预措施: Knowledge assessment (Behavioral)

Organization Level

Other

干预措施: Knowledge assessment (Behavioral)

Provider Level

Other

干预措施: Knowledge assessment (Behavioral)

Provider Level

Other

干预措施: Education Intervention (Behavioral)

Provider Level

Other

干预措施: Provider Feedback (Behavioral)

结局指标

主要结局

Change in proportion of PLWH with cardiovascular risk factors seen by a physician receiving statin therapy

时间窗: 12 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Allison L. Diamant

Principal Investigator

University of California, Los Angeles

研究点 (8)

Loading locations...

相似试验